J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 8,540.00
0.00 (0.00%)
At close: Feb 19, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 49.24 billion as of February 20, 2026. Its market cap has decreased by -6.34% in one year.
Market Cap
49.24B
Enterprise Value
39.02B
Revenue
31.12B
Ranking
n/a
PE Ratio
21.74
Stock Price
8,540.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 49.24B, a decrease of -66.03%. That is a compound annual growth rate of -43.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 49.24B | -2.09% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 71.25B |
| Ark Solutions | 68.91B |
| SunBio,Inc. | 67.31B |
| EyeGene | 62.12B |
| NGeneBio | 57.46B |
| Aptamer Sciences | 44.28B |
| MOA Life Plus | 44.07B |
| SCM Lifescience | 37.31B |